Ras Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 9.99 Cr
- Paid Up Capital ₹ 9.99 Cr
- Company Age 16 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 5.14 M
About Ras Life Sciences
Ras Life Sciences Private Limited (RLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 February 2008 and has a history of 16 years and 11 months. Its registered office is in Delhi, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 9.99 Cr and a paid-up capital of Rs 9.99 Cr.
The company has closed loans amounting to ₹5.14 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Anil Agarwal, Pierra Charbonner, and Rajan Nagar serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33110DL2008PTC378612
-
Company No.
070383
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Feb 2008
-
Date of AGM
23 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Ras Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Agarwal
|
Director | 16-Dec-2021 | Current |
Pierra Charbonner
|
Director | 29-Sep-2015 | Current |
|
Rajan Nagar
|
Director | 28-Jun-2016 | Current |
Financial Performance of Ras Life Sciences.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ras Life Sciences?
Unlock access to Ras Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Biomerieux India Private LimitedAnil Agarwal and Rajan Nagar are mutual person
Charges (Loans)
₹0
₹0.51 Cr
Charges Breakdown by Lending Institutions
- Department Of Biotechnology : 0.26 Cr
- Ikp Knowledge Park : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Mar 2012 | Department Of Biotechnology | ₹0.91 M | Satisfied |
| 21 Jun 2011 | Department Of Biotechnology | ₹1.74 M | Satisfied |
| 18 Feb 2011 | Ikp Knowledge Park | ₹2.50 M | Satisfied |
How Many Employees Work at Ras Life Sciences?
Unlock and access historical data on people associated with Ras Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ras Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ras Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
